KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Capital Expenditures: 2009-2025

Historic Capital Expenditures for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $91.0 million.

  • Bausch Health Companies' Capital Expenditures rose 28.17% to $91.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $411.0 million, marking a year-over-year increase of 24.92%. This contributed to the annual value of $337.0 million for FY2024, which is 56.74% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Capital Expenditures is $91.0 million, which was down 8.08% from $99.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Capital Expenditures registered a high of $115.0 million during Q1 2025, and its lowest value of $28.0 million during Q2 2023.
  • For the 3-year period, Bausch Health Companies' Capital Expenditures averaged around $77.9 million, with its median value being $82.0 million (2024).
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 46.15% in 2023, then skyrocketed by 178.57% in 2024.
  • Bausch Health Companies' Capital Expenditures (Quarterly) stood at $78.0 million in 2021, then fell by 15.38% to $66.0 million in 2022, then skyrocketed by 48.48% to $98.0 million in 2023, then rose by 8.16% to $106.0 million in 2024, then rose by 28.17% to $91.0 million in 2025.
  • Its Capital Expenditures was $91.0 million in Q3 2025, compared to $99.0 million in Q2 2025 and $115.0 million in Q1 2025.